Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinib
SourceBone Marrow Transplantation, 53, 10, (2018), pp. 1255-1262
Article / Letter to editor
Display more detailsDisplay less details
Bone Marrow Transplantation
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence RIHS: Radboud Institute for Health Sciences; Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.